{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:36:28Z","timestamp":1792816588156,"version":"4.5.0"},"reference-count":388,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000033","name":"Institute of Musculoskeletal Health and Arthritis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000033","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["pharmrev.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reviews"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.pharmr.2026.100144","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T19:30:27Z","timestamp":1779305427000},"page":"100144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Mast cell proteases and their significance in physiology, pathology, and therapeutic approaches"],"prefix":"10.1016","volume":"78","author":[{"given":"Afshin","family":"Derakhshani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leela","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1291-2376","authenticated-orcid":false,"given":"Kyle","family":"Lesack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navid","family":"Saranjam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khashayarsha","family":"Khazaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Pejler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Krawetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6810-6149","authenticated-orcid":false,"given":"Laura E.","family":"Edgington-Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4909-6061","authenticated-orcid":false,"given":"Henry R.","family":"Maun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3429-4188","authenticated-orcid":false,"given":"Antoine","family":"Dufour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.pharmr.2026.100144_bib1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/mi.2009.136","article-title":"Advances in mast cell biology: new understanding of heterogeneity and function","volume":"3","author":"Moon","year":"2010","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.pharmr.2026.100144_bib2","series-title":"Encyclopedia of Microbiology","first-page":"496","article-title":"Phagocytes (innate immunity)","author":"DeLeo","year":"2019"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100144_bib3","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1189\/jlb.4MR0217-048RR","article-title":"Granulocytes as modulators of dendritic cell function","volume":"102","author":"Breedveld","year":"2017","journal-title":"J Leukoc Biol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100144_bib4","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/s41590-023-01493-2","article-title":"Slow integrin-dependent migration organizes networks of tissue-resident mast cells","volume":"24","author":"Kaltenbach","year":"2023","journal-title":"Nat Immunol"},{"key":"10.1016\/j.pharmr.2026.100144_bib5","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3389\/fimmu.2014.00453","article-title":"Vesicular trafficking and signaling for cytokine and chemokine secretion in mast cells","volume":"5","author":"Blank","year":"2014","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100144_bib6","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nri3690","article-title":"Mast cell secretory granules: armed for battle","volume":"14","author":"Wernersson","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.pharmr.2026.100144_bib7","series-title":"Encyclopedia of Medical Immunology","first-page":"503","article-title":"Morphology and histologic identification of mast cells","author":"Akin","year":"2014"},{"key":"10.1016\/j.pharmr.2026.100144_bib8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0065-2776(07)95006-3","article-title":"Mast cell proteases","volume":"95","author":"Pejler","year":"2007","journal-title":"Adv Immunol"},{"issue":"6281","key":"10.1016\/j.pharmr.2026.100144_bib9","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/346274a0","article-title":"Mast cells as a source of both preformed and immunologically inducible TNF-\u03b1\/cachectin","volume":"346","author":"Gordon","year":"1990","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100144_bib10","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1084\/jem.20090805","article-title":"Mast cell\u2013derived particles deliver peripheral signals to remote lymph nodes","volume":"206","author":"Kunder","year":"2009","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100144_bib11","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1046\/j.1365-2222.2000.00756.x","article-title":"Localization of interleukin (IL) \u22124 but not IL-5 to human mast cell secretory granules by immunoelectron microscopy","volume":"30","author":"Wilson","year":"2000","journal-title":"Clin Experimental Allergy"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100144_bib12","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.4049\/jimmunol.174.2.1063","article-title":"Mast cells, basophils, and eosinophils acquire constitutive IL-4 and IL-13 transcripts during lineage differentiation that are sufficient for rapid cytokine production","volume":"174","author":"Gessner","year":"2005","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100144_bib13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/ni1158","article-title":"Mast cells in the development of adaptive immune responses","volume":"6","author":"Galli","year":"2005","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100144_bib14","first-page":"27","article-title":"Biomarkers in the diagnosis of mast cell activation","volume":"25","author":"Voelker","year":"2024","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100144_bib15","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.4049\/jimmunol.131.6.2958","article-title":"Antigen-initiated release of platelet-activating factor (PAF-acether) from mouse bone marrow-derived mast cells sensitized with monoclonal IgE","volume":"131","author":"Mencia-Huerta","year":"1983","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100144_bib16","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.jaci.2025.05.022","article-title":"Mast cells modulate macrophage biology through release of prestored CSF1","volume":"156","author":"Kovacs","year":"2025","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100144_bib17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/imr.12634","article-title":"Mast cells as sources of cytokines, chemokines, and growth factors","volume":"282","author":"Mukai","year":"2018","journal-title":"Immunol Rev"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100144_bib18","doi-asserted-by":"crossref","DOI":"10.1111\/exd.70173","article-title":"The role of mast cells in skin aging: mechanisms and therapeutic advances","volume":"34","author":"Zhou","year":"2025","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.pharmr.2026.100144_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1738487","article-title":"Mast cells in the bone marrow microenvironment","volume":"16","author":"Ribatti","year":"2026","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100144_bib20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41577-022-00731-2","article-title":"New perspectives on the origins and heterogeneity of mast cells","volume":"23","author":"St John","year":"2023","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100144_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2012.214","article-title":"Mast cells rescue implantation defects caused by c-kit deficiency","volume":"4","author":"Woidacki","year":"2013","journal-title":"Cell Death Dis"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100144_bib22","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.jaci.2024.12.1092","article-title":"Update on mast cell biology","volume":"155","author":"Pahima","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.pharmr.2026.100144_bib23","first-page":"1","article-title":"Mast cell extracellular granules are bioactive condensates assembled by heparin and polyamine","author":"Xiong","year":"2026","journal-title":"Nat Chem Biol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100144_bib24","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1001\/jama.1960.73020200009012","article-title":"Tissue mast cells","volume":"173","author":"Fisher","year":"1960","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100144_bib25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/eji.200838899","article-title":"Our perception of the mast cell from Paul Ehrlich to now","volume":"39","author":"Beaven","year":"2009","journal-title":"Eur J Immunol"},{"issue":"32","key":"10.1016\/j.pharmr.2026.100144_bib26","doi-asserted-by":"crossref","first-page":"11129","DOI":"10.1073\/pnas.0505073102","article-title":"Mast cell-committed progenitors","volume":"102","author":"Kitamura","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100144_bib27","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.4049\/jimmunol.146.5.1410","article-title":"Demonstration of the origin of human mast cells from CD34+ bone marrow progenitor cells","volume":"146","author":"Kirshenbaum","year":"1991","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100144_bib28","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.immuni.2010.11.011","article-title":"Neutrophils, from marrow to microbes","volume":"33","author":"Borregaard","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.pharmr.2026.100144_bib29","series-title":"Mast Cells and Tumours","first-page":"3","article-title":"The mast cell","author":"Ribatti","year":"2011"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100144_bib30","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1182\/blood.V9.12.1123.1123","article-title":"Heparin, histamine and mast cells","volume":"9","author":"Riley","year":"1954","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100144_bib31","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.2042-7158.1959.tb12591.x","article-title":"Tissue mast cells and tissue amines","volume":"11","author":"West","year":"1959","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100144_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.108069","article-title":"Mast cells in digestive diseases: new insights to keep them under control","volume":"223","author":"Bilgic","year":"2026","journal-title":"Pharmacol Res"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100144_bib33","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.3390\/cells10071615","article-title":"Two sides of the coin: mast cells as a key regulator of allergy and acute\/chronic inflammation","volume":"10","author":"Zhang","year":"2021","journal-title":"Cells"},{"issue":"19","key":"10.1016\/j.pharmr.2026.100144_bib34","doi-asserted-by":"crossref","first-page":"5316","DOI":"10.1016\/j.cell.2024.07.014","article-title":"Neutrophil trapping and nexocytosis, mast cell-mediated processes for inflammatory signal relay","volume":"187","author":"Mihlan","year":"2024","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100144_bib35","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.bbrc.2014.07.124","article-title":"Ancient origin of mast cells","volume":"451","author":"Wong","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100144_bib36","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jaci.2022.08.011","article-title":"Defining mast cell differentiation and heterogeneity through single-cell transcriptomics analysis","volume":"150","author":"Derakhshan","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"46","key":"10.1016\/j.pharmr.2026.100144_bib37","doi-asserted-by":"crossref","first-page":"36189","DOI":"10.1074\/jbc.M005830200","article-title":"Occurrence of heparin in the invertebrate Styela plicata (Tunicata) is restricted to cell layers facing the outside environment?","volume":"275","author":"Cavalcante","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2026.100144_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1433982","article-title":"Pharmacological blockade of the mast cell MRGPRX2 receptor supports investigation of its relevance in skin disorders","volume":"15","author":"Macphee","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.pharmr.2026.100144_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/falgy.2024.1373511","article-title":"Functional human skin explants as tools for assessing mast cell activation and inhibition","volume":"5","author":"Villanueva","year":"2024","journal-title":"Front Allergy"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100144_bib40","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.micron.2007.01.007","article-title":"Phagocytosis of latex beads and bacteria by hemocytes of the triatomine bug Rhodnius prolixus (Hemiptera: Reduvidae)","volume":"39","author":"Borges","year":"2008","journal-title":"Micron"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100144_bib41","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/apm.13264","article-title":"Do mast cells contribute to the continued survival of vertebrates?","volume":"130","author":"Norrby","year":"2022","journal-title":"APMIS"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100144_bib42","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2019.01.048","article-title":"Mast cells: promoters of health and modulators of disease","volume":"144","author":"Maurer","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"23","key":"10.1016\/j.pharmr.2026.100144_bib43","doi-asserted-by":"crossref","first-page":"10743","DOI":"10.7150\/thno.46719","article-title":"Mast cells as a unique hematopoietic lineage and cell system: from Paul Ehrlich\u2019s visions to precision medicine concepts","volume":"10","author":"Valent","year":"2020","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100144_bib44","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.immuni.2020.01.012","article-title":"Human mast cell proteome reveals unique lineage, putative functions, and structural basis for cell ablation","volume":"52","author":"Plum","year":"2020","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100144_bib45","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/imr.13191","article-title":"Mast cell ontogeny: from fetal development to life-long health and disease","volume":"315","author":"Chia","year":"2023","journal-title":"Immunol Rev"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100144_bib46","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.immuni.2018.04.025","article-title":"Hemogenic endothelial fate mapping reveals dual developmental origin of mast cells","volume":"48","author":"Gentek","year":"2018","journal-title":"Immunity"},{"issue":"19","key":"10.1016\/j.pharmr.2026.100144_bib47","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1016\/j.devcel.2024.06.010","article-title":"Human yolk sac-derived innate lymphoid-biased multipotent progenitors emerge prior to hematopoietic stem cell formation","volume":"59","author":"Ni","year":"2024","journal-title":"Dev Cell"},{"issue":"16","key":"10.1016\/j.pharmr.2026.100144_bib48","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1182\/blood-2017-09-802173","article-title":"Resolution of a human mast cell development conundrum","volume":"130","author":"Austen","year":"2017","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100144_bib49","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20230570","article-title":"Landscape of mast cell populations across organs in mice and humans","volume":"220","author":"Tauber","year":"2023","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100144_bib50","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.immuni.2018.09.023","article-title":"Adult connective tissue-resident mast cells originate from late erythro-myeloid progenitors","volume":"49","author":"Li","year":"2018","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100144_bib51","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1084\/jem.110.3.451","article-title":"An enzyme in mast cells with properties like chymotrypsin","volume":"110","author":"Benditt","year":"1959","journal-title":"J Exp Med"},{"issue":"4716","key":"10.1016\/j.pharmr.2026.100144_bib52","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/185846a0","article-title":"Histochemical demonstration of a species-specific trypsin-like enzyme in mast cells","volume":"185","author":"Glenner","year":"1960","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100144_bib53","doi-asserted-by":"crossref","first-page":"962","DOI":"10.4049\/jimmunol.137.3.962","article-title":"Identification of a chymotrypsin-like proteinase in human mast cells","volume":"137","author":"Schechter","year":"1986","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100144_bib54","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1749-6632.1963.tb53698.x","article-title":"Proteolytic enzymes of mast cells","volume":"103","author":"Lagunoff","year":"1963","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100144_bib55","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1749-6632.1963.tb53690.x","article-title":"The in vitro differentiation and culture of normal mast cells from the mouse thymus","volume":"103","author":"Ginsburg","year":"1963","journal-title":"Ann N Y Acad Sci"},{"issue":"22","key":"10.1016\/j.pharmr.2026.100144_bib56","doi-asserted-by":"crossref","first-page":"11939","DOI":"10.1016\/S0021-9258(19)68496-6","article-title":"Tryptase from human pulmonary mast cells. Purification and characterization","volume":"256","author":"Schwartz","year":"1981","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100144_bib57","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.4049\/jimmunol.139.8.2724","article-title":"Detection and partial characterization of a human mast cell carboxypeptidase","volume":"139","author":"Goldstein","year":"1987","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100144_bib58","doi-asserted-by":"crossref","first-page":"840","DOI":"10.4049\/jimmunol.97.6.840","article-title":"Physicochemical properties of reaginic antibody","volume":"97","author":"Ishizaka","year":"1966","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100144_bib59","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/apm.1966.66.3.303","article-title":"Mast cells in rat gastrointestinal mucosa. 2. Dye-binding and metachromatic properties","volume":"66","author":"Enerb\u00e4ck","year":"1966","journal-title":"Acta Pathol Microbiol Scand"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100144_bib60","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1182\/blood.V52.2.447.447","article-title":"Decrease of mast cells in W\/Wv mice and their increase by bone marrow transplantation","volume":"52","author":"Kitamura","year":"1978","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100144_bib61","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1017\/S001667230002098X","article-title":"A new allele sash (Wsh) at the W-locus and a spontaneous recessive lethal in mice","volume":"39","author":"Lyon","year":"1982","journal-title":"Genet Res"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100144_bib62","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1073\/pnas.83.12.4464","article-title":"Two types of human mast cells that have distinct neutral protease compositions","volume":"83","author":"Irani","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100144_bib63","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1002\/j.1460-2075.1987.tb02655.x","article-title":"Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand","volume":"6","author":"Yarden","year":"1987","journal-title":"EMBO J"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100144_bib64","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0092-8674(90)90297-R","article-title":"Identification of a ligand for the c-kit proto-oncogene","volume":"63","author":"Williams","year":"1990","journal-title":"Cell"},{"issue":"23","key":"10.1016\/j.pharmr.2026.100144_bib65","doi-asserted-by":"crossref","first-page":"10560","DOI":"10.1073\/pnas.92.23.10560","article-title":"Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder","volume":"92","author":"Nagata","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100144_bib66","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/dvg.20378","article-title":"Generation and characterization of alpha-chymase-Cre transgenic mice","volume":"46","author":"M\u00fcsch","year":"2008","journal-title":"Genesis"},{"issue":"26","key":"10.1016\/j.pharmr.2026.100144_bib67","doi-asserted-by":"crossref","first-page":"6930","DOI":"10.1182\/blood-2011-03-343962","article-title":"Reduced mast cell and basophil numbers and function in Cpa3-Cre; Mcl-1fl\/fl mice","volume":"118","author":"Lilla","year":"2011","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100144_bib68","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.immuni.2011.09.015","article-title":"Cre-mediated cell ablation contests mast cell contribution in models of antibody-and T cell-mediated autoimmunity","volume":"35","author":"Feyerabend","year":"2011","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100144_bib69","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.immuni.2011.03.028","article-title":"Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens","volume":"34","author":"Dudeck","year":"2011","journal-title":"Immunity"},{"issue":"7542","key":"10.1016\/j.pharmr.2026.100144_bib70","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature14022","article-title":"Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions","volume":"519","author":"McNeil","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.pharmr.2026.100144_bib71","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.bbrc.2021.03.025","article-title":"New inducible mast cell-deficient mouse model (Mcpt5\/Cma1DTR)","volume":"551","author":"Sasaki","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100144_bib72","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.it.2021.04.004","article-title":"Understanding mast cell heterogeneity at single cell resolution","volume":"42","author":"Cildir","year":"2021","journal-title":"Trends Immunol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100144_bib73","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1159\/000506985","article-title":"Novel insight into the in vivo function of mast cell chymase: lessons from knockouts and inhibitors","volume":"12","author":"Pejler","year":"2020","journal-title":"J Innate Immun"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100144_bib74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143091","article-title":"Granule associated serine proteases of hematopoietic cells\u2013an analysis of their appearance and diversification during vertebrate evolution","volume":"10","author":"Akula","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100144_bib75","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3390\/cells10020309","article-title":"Lung mast cells have a high constitutive expression of carboxypeptidase A3 mRNA that is independent from granule-stored CPA3","volume":"10","author":"Siddhuraj","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.pharmr.2026.100144_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.dci.2021.104273","article-title":"Analysis of the mast cell expressed carboxypeptidase A3 and its structural and evolutionary relationship to other vertebrate carboxypeptidases","volume":"127","author":"Akula","year":"2022","journal-title":"Dev Comp Immunol"},{"issue":"34","key":"10.1016\/j.pharmr.2026.100144_bib77","doi-asserted-by":"crossref","first-page":"14210","DOI":"10.1073\/pnas.1111048108","article-title":"Protease phenotype of constitutive connective tissue and of induced mucosal mast cells in mice is regulated by the tissue","volume":"108","author":"Xing","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmr.2026.100144_bib78","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.932090","article-title":"Mast cell tissue heterogeneity and specificity of immune cell recruitment","volume":"13","author":"West","year":"2022","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100144_bib79","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/ni.3445","article-title":"Expression profiling of constitutive mast cells reveals a unique identity within the immune system","volume":"17","author":"Dwyer","year":"2016","journal-title":"Nat Immunol"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100144_bib80","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1002\/1521-4141(200010)30:10<2954::AID-IMMU2954>3.0.CO;2-S","article-title":"Reversible expression of tryptases in continuous L138. 8A mast cells","volume":"30","author":"Rupp","year":"2000","journal-title":"Eur J Immunol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100144_bib81","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.jaci.2022.04.012","article-title":"KIT as a master regulator of the mast cell lineage","volume":"149","author":"Tsai","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100144_bib82","doi-asserted-by":"crossref","first-page":"5428","DOI":"10.4049\/jimmunol.1103366","article-title":"Stem cell factor programs the mast cell activation phenotype","volume":"188","author":"Ito","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmr.2026.100144_bib83","series-title":"Interleukin-6 and Mast Cells","author":"Conti","year":"2002"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100144_bib84","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.4049\/jimmunol.160.11.5537","article-title":"Reversible expression of tryptases and chymases in the jejunal mast cells of mice infected with Trichinella spiralis","volume":"160","author":"Friend","year":"1998","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100144_bib85","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1111\/all.16036","article-title":"CXCL17 induces activation of human mast cells via MRGPRX2","volume":"79","author":"Ding","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.pharmr.2026.100144_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2025.108892","article-title":"Current and future therapeutics targeting mast cells in disease","volume":"273","author":"Worrall","year":"2025","journal-title":"Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100144_bib87","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1385\/IR:34:2:97","article-title":"Development, migration, and survival of mast cells","volume":"34","author":"Okayama","year":"2006","journal-title":"Immunol Res"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100144_bib88","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S1074-7613(01)00157-1","article-title":"Regulation of mast cell survival by IgE","volume":"14","author":"Asai","year":"2001","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100144_bib89","first-page":"965","article-title":"The c-kit receptor, stem cell factor, and mast cells. What each is teaching us about the others","volume":"142","author":"Galli","year":"1993","journal-title":"Am J Pathol"},{"issue":"22","key":"10.1016\/j.pharmr.2026.100144_bib90","doi-asserted-by":"crossref","first-page":"12911","DOI":"10.1073\/pnas.1735525100","article-title":"Evidence that IgE molecules mediate a spectrum of effects on mast cell survival and activation via aggregation of the Fc\u03b5RI","volume":"100","author":"Kitaura","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100144_bib91","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.jaci.2005.08.042","article-title":"Monomeric IgE enhances human mast cell chemokine production: il-4 augments and dexamethasone suppresses the response","volume":"116","author":"Matsuda","year":"2005","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100144_bib92","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2172-9-2","article-title":"IgE alone promotes human lung mast cell survival through the autocrine production of IL-6","volume":"9","author":"Cruse","year":"2008","journal-title":"BMC Immunol"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100144_bib93","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1369\/0022155414545334","article-title":"Mast cell function: a new vision of an old cell","volume":"62","author":"da Silva","year":"2014","journal-title":"J Histochem Cytochem"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100144_bib94","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0002-9440(10)62055-X","article-title":"Mast cell-deficient W-sash c-kit mutant KitW-sh\/W-sh mice as a model for investigating mast cell biology in vivo","volume":"167","author":"Grimbaldeston","year":"2005","journal-title":"Am J Pathol"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100144_bib95","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1164\/rccm.2105025","article-title":"The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study","volume":"165","author":"Hattotuwa","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100144_bib96","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000513582","article-title":"Novel strategies to target mast cells in disease","volume":"13","author":"Paivandy","year":"2021","journal-title":"J Innate Immun"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100144_bib97","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1182\/blood-2004-12-4792","article-title":"Stem cell factor promotes mast cell survival via inactivation of FOXO3a-mediated transcriptional induction and MEK-regulated phosphorylation of the proapoptotic protein Bim","volume":"106","author":"M\u00f6ller","year":"2005","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100144_bib98","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jaci.2021.03.049","article-title":"Multifaceted MRGPRX2: new insight into the role of mast cells in health and disease","volume":"148","author":"Roy","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100144_bib99","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41392-025-02209-8","article-title":"Subnanomolar MAS-related G protein-coupled receptor-X2\/B2 antagonists with efficacy in human mast cells and disease models","volume":"10","author":"Al Hamwi","year":"2025","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100144_bib100","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.990","article-title":"The effect of substance P and its common in vivo-formed metabolites on MRGPRX2 and human mast cell activation","volume":"10","author":"Hsin","year":"2022","journal-title":"Pharmacol Res Perspect"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100144_bib101","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.neuron.2019.01.012","article-title":"A mast-cell-specific receptor mediates neurogenic inflammation and pain","volume":"101","author":"Green","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.pharmr.2026.100144_bib102","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.812774","article-title":"Toll-like receptor signaling and its role in cell-mediated immunity","volume":"13","author":"Duan","year":"2022","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100144_bib103","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.4049\/jimmunol.0803180","article-title":"Inducible MHC class II expression by mast cells supports effector and regulatory T cell activation","volume":"182","author":"Kambayashi","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmr.2026.100144_bib104","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3389\/fimmu.2012.00120","article-title":"Mast cell: an emerging partner in immune interaction","volume":"3","author":"Gri","year":"2012","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100144_bib105","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.immuni.2009.08.022","article-title":"Mast cell-mediated antigen presentation regulates CD8+ T cell effector functions","volume":"31","author":"Stelekati","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.pharmr.2026.100144_bib106","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.688347","article-title":"Mast cells modulate antigen-specific CD8+ T cell activation during LCMV infection","volume":"12","author":"Hackler","year":"2021","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100144_bib107","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.jaci.2017.04.006","article-title":"Prevalence of food allergies and intolerances documented in electronic health records","volume":"140","author":"Acker","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100144_bib108","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3132\/pcrj.2007.00006","article-title":"Gender-specific presentations for asthma, allergic rhinitis and eczema in primary care","volume":"16","author":"Osman","year":"2007","journal-title":"Prim Care Respir J"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100144_bib109","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.jaci.2007.07.040","article-title":"Trends in hospitalizations for anaphylaxis, angioedema, and urticaria in Australia, 1993\u20131994 to 2004\u20132005","volume":"120","author":"Poulos","year":"2007","journal-title":"J Allergy Clin Immunol"},{"issue":"38","key":"10.1016\/j.pharmr.2026.100144_bib110","doi-asserted-by":"crossref","first-page":"23751","DOI":"10.1073\/pnas.1915075117","article-title":"Perinatal androgens organize sex differences in mast cells and attenuate anaphylaxis severity into adulthood","volume":"117","author":"Mackey","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100144_bib111","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a039172","article-title":"Sex differences in mast cell-associated disorders: a life span perspective","volume":"14","author":"Mackey","year":"2022","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100144_bib112","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S1474-4422(06)70581-6","article-title":"Sex ratio of multiple sclerosis in Canada: a longitudinal study","volume":"5","author":"Orton","year":"2006","journal-title":"Lancet Neurol"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100144_bib113","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1001\/jamaneurol.2024.2876","article-title":"Updated multiple sclerosis incidence, 2015\u20132022","volume":"81","author":"Graf","year":"2024","journal-title":"JAMA Neurol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100144_bib114","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.autrev.2004.09.002","article-title":"Epidemiology of adult rheumatoid arthritis","volume":"4","author":"Alamanos","year":"2005","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100144_bib115","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1046\/j.1365-2982.2000.00221.x","article-title":"Increased mast cells in the irritable bowel syndrome","volume":"12","author":"O\u2019Sullivan","year":"2000","journal-title":"Neurogastroenterology Motil"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100144_bib116","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1053\/j.gastro.2003.11.055","article-title":"Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome","volume":"126","author":"Barbara","year":"2004","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100144_bib117","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0022-5347(17)42981-8","article-title":"Increased mast cells of the bladder in suspected cases of interstitial cystitis: a possible disease marker","volume":"138","author":"Feltis","year":"1987","journal-title":"J Urol"},{"key":"10.1016\/j.pharmr.2026.100144_bib118","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3389\/fimmu.2012.00169","article-title":"Role of female sex hormones, estradiol and progesterone, in mast cell behavior","volume":"3","author":"Zierau","year":"2012","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100144_bib119","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1016\/j.molimm.2006.09.030","article-title":"Estradiol activates mast cells via a non-genomic estrogen receptor-\u03b1 and calcium influx","volume":"44","author":"Zaitsu","year":"2007","journal-title":"Mol Immunol"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100144_bib120","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1172\/JCI119336","article-title":"Glucocorticoids decrease tissue mast cell number by reducing the production of the c-kit ligand, stem cell factor, by resident cells: in vitro and in vivo evidence in murine systems","volume":"99","author":"Finotto","year":"1997","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100144_bib121","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/sj.icb.7100166","article-title":"Receptors for complement C5a. The importance of C5aR and the enigmatic role of C5L2","volume":"86","author":"Lee","year":"2008","journal-title":"Immunol Cell Biol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100144_bib122","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2172-9-29","article-title":"Mast cell activation is characterized by upregulation of a functional anaphylatoxin C5a receptor","volume":"9","author":"Soruri","year":"2008","journal-title":"BMC Immunol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100144_bib123","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jaci.2012.05.009","article-title":"Mast cell anaphylatoxin receptor expression can enhance IgE-dependent skin inflammation in mice","volume":"131","author":"Sch\u00e4fer","year":"2013","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100144_bib124","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.jaci.2005.02.022","article-title":"Surface CD88 functionally distinguishes the MCTC from the MCT type of human lung mast cell","volume":"115","author":"Oskeritzian","year":"2005","journal-title":"J Allergy Clin Immunol"},{"issue":"56","key":"10.1016\/j.pharmr.2026.100144_bib125","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abb7221","article-title":"Human airway mast cells proliferate and acquire distinct inflammation-driven phenotypes during type 2 inflammation","volume":"6","author":"Dwyer","year":"2021","journal-title":"Sci Immunol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100144_bib126","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jaci.2020.12.654","article-title":"PD-L1 on mast cells suppresses effector CD8+ T-cell activation in the skin in murine contact hypersensitivity","volume":"148","author":"Hirano","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.pharmr.2026.100144_bib127","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.3389\/fimmu.2018.01873","article-title":"The role of histamine and histamine receptors in mast cell-mediated allergy and inflammation: the Hunt for new therapeutic targets","volume":"9","author":"Thangam","year":"2018","journal-title":"Front Immunol"},{"issue":"6444","key":"10.1016\/j.pharmr.2026.100144_bib128","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/365340a0","article-title":"Induction of human IgE synthesis in B cells by mast cells and basophils","volume":"365","author":"Gauchat","year":"1993","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.pharmr.2026.100144_bib129","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1182\/blood-2009-10-250126","article-title":"Mast cells enhance proliferation of B lymphocytes and drive their differentiation toward IgA-secreting plasma cells","volume":"115","author":"Merluzzi","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.pharmr.2026.100144_bib130","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.718499","article-title":"Mast cell modulation of B cell responses: an under-appreciated partnership in host defence","volume":"12","author":"Palma","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100144_bib131","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s004240050493","article-title":"Mast cell-mediated induction of ICAM-1, VCAM-1 and E-selectin in endothelial cells in vitro: constitutive release of inducing mediators but no effect of degranulation","volume":"435","author":"van Haaster","year":"1997","journal-title":"Pflug Arch"},{"issue":"22","key":"10.1016\/j.pharmr.2026.100144_bib132","doi-asserted-by":"crossref","first-page":"8972","DOI":"10.1073\/pnas.86.22.8972","article-title":"Degranulation of human mast cells induces an endothelial antigen central to leukocyte adhesion","volume":"86","author":"Klein","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmr.2026.100144_bib133","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fimmu.2012.00119","article-title":"Mast cell chemotaxis\u2013chemoattractants and signaling pathways","volume":"3","author":"Halova","year":"2012","journal-title":"Front Immunol"},{"key":"10.1016\/j.pharmr.2026.100144_bib134","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3389\/fncel.2019.00294","article-title":"Mast cell\/proteinase activated receptor 2 (PAR2) mediated interactions in the pathogenesis of discogenic back pain","volume":"13","author":"Richards","year":"2019","journal-title":"Front Cell Neurosci"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100144_bib135","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.jaci.2009.01.044","article-title":"Vascular endothelial growth factors synthesized by human lung mast cells exert angiogenic effects","volume":"123","author":"Detoraki","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.pharmr.2026.100144_bib136","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3389\/fimmu.2012.00134","article-title":"Mast cell adenosine receptors function: a focus on the a3 adenosine receptor and inflammation","volume":"3","author":"Rudich","year":"2012","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100144_bib137","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.4049\/jimmunol.177.5.3439","article-title":"Leukotriene B4 receptors BLT1 and BLT2: expression and function in human and murine mast cells","volume":"177","author":"Lundeen","year":"2006","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100144_bib138","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1002\/eji.201545501","article-title":"Activated mast cells synthesize and release soluble ST2-a decoy receptor for IL-33","volume":"45","author":"Bandara","year":"2015","journal-title":"Eur J Immunol"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100144_bib139","doi-asserted-by":"crossref","first-page":"4352","DOI":"10.1096\/fj.08-113274","article-title":"Cysteinyl leukotriene 2 receptor-mediated vascular permeability via transendothelial vesicle transport","volume":"22","author":"Moos","year":"2008","journal-title":"FASEB J"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100144_bib140","doi-asserted-by":"crossref","first-page":"4927","DOI":"10.4049\/jimmunol.1100806","article-title":"Serglycin: a structural and functional chameleon with wide impact on immune cells","volume":"187","author":"Kolset","year":"2011","journal-title":"J Immunol"},{"issue":"1\u20132","key":"10.1016\/j.pharmr.2026.100144_bib141","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1515\/BC-2011-220","article-title":"Mast cells express tyrosine hydroxylase and store dopamine in a serglycin-dependent manner","volume":"393","author":"R\u00f6nnberg","year":"2012","journal-title":"Biol Chem"},{"issue":"6746","key":"10.1016\/j.pharmr.2026.100144_bib142","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/23488","article-title":"Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme","volume":"400","author":"Forsberg","year":"1999","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100144_bib143","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1042\/BJ20061257","article-title":"Serglycin proteoglycan is required for secretory granule integrity in mucosal mast cells","volume":"403","author":"Braga","year":"2007","journal-title":"Biochem J"},{"issue":"39","key":"10.1016\/j.pharmr.2026.100144_bib144","doi-asserted-by":"crossref","first-page":"40897","DOI":"10.1074\/jbc.M405856200","article-title":"Serglycin is essential for maturation of mast cell secretory granule","volume":"279","author":"\u00c5brink","year":"2004","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100144_bib145","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.jaci.2007.11.031","article-title":"Serotonin and histamine storage in mast cell secretory granules is dependent on serglycin proteoglycan","volume":"121","author":"Ringvall","year":"2008","journal-title":"J Allergy Clin Immunol"},{"issue":"16","key":"10.1016\/j.pharmr.2026.100144_bib146","doi-asserted-by":"crossref","first-page":"7372","DOI":"10.1016\/S0021-9258(17)38401-6","article-title":"Regulation of tryptase from human lung mast cells by heparin. Stabilization of the active tetramer","volume":"261","author":"Schwartz","year":"1986","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100144_bib147","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1432-1033.1995.192_1.x","article-title":"Regulation of rat mast cell protease 1 activity. Protease inhibition is prevented by heparin proteoglycan","volume":"233","author":"Pejler","year":"1995","journal-title":"Eur J Biochem"},{"issue":"37","key":"10.1016\/j.pharmr.2026.100144_bib148","doi-asserted-by":"crossref","first-page":"12187","DOI":"10.1021\/bi991046b","article-title":"Mechanism by which heparin proteoglycan modulates mast cell chymase activity","volume":"38","author":"Pejler","year":"1999","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100144_bib149","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.molimm.2007.06.360","article-title":"The extended cleavage specificity of the rodent \u03b2-chymases rMCP-1 and mMCP-4 reveal major functional similarities to the human mast cell chymase","volume":"45","author":"Andersson","year":"2008","journal-title":"Mol Immunol"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100144_bib150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207826","article-title":"Extended cleavage specificities of mast cell proteases 1 and 2 from golden hamster: classical chymase and an elastolytic protease comparable to rat and mouse MCP-5","volume":"13","author":"Thorpe","year":"2018","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100144_bib151","doi-asserted-by":"crossref","first-page":"9291","DOI":"10.1074\/jbc.M410396200","article-title":"A key role for mast cell chymase in the activation of pro-matrix metalloprotease-9 and pro-matrix metalloprotease-2","volume":"280","author":"Tchougounova","year":"2005","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100144_bib152","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1006\/geno.1993.1115","article-title":"The human mast cell chymase gene (CMA1): mapping to the cathepsin G\/granzyme gene cluster and lineage-restricted expression","volume":"15","author":"Caughey","year":"1993","journal-title":"Genomics"},{"key":"10.1016\/j.pharmr.2026.100144_bib153","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1040493","article-title":"Differential protease content of mast cells and the processing of IL-33 in Alternaria alternata induced allergic airway inflammation in mice","volume":"14","author":"Krysko","year":"2023","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100144_bib155","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1084\/jem.20030671","article-title":"The chymase, mouse mast cell protease 4, constitutes the major chymotrypsin-like activity in peritoneum and ear tissue. A role for mouse mast cell protease 4 in thrombin regulation and fibronectin turnover","volume":"198","author":"Tchougounova","year":"2003","journal-title":"J Exp Med"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100144_bib156","doi-asserted-by":"crossref","first-page":"7285","DOI":"10.4049\/jimmunol.174.11.7285","article-title":"Mast cell protease 5 mediates ischemia-reperfusion injury of mouse skeletal muscle","volume":"174","author":"Abonia","year":"2005","journal-title":"J Immunol"},{"issue":"24","key":"10.1016\/j.pharmr.2026.100144_bib157","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.1182\/blood-2010-01-257287","article-title":"Mast cell proteases: multifaceted regulators of inflammatory disease, The Journal of the American Society of Hematology","volume":"115","author":"Pejler","year":"2010","journal-title":"Blood"},{"issue":"46","key":"10.1016\/j.pharmr.2026.100144_bib158","doi-asserted-by":"crossref","first-page":"29158","DOI":"10.1074\/jbc.272.46.29158","article-title":"Mouse mast cell protease 9, a novel member of the chromosome 14 family of serine proteases that is selectively expressed in uterine mast cells","volume":"272","author":"Hunt","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2026.100144_bib159","article-title":"Cutting Edge\u2013Cleavage Specificity and Biochemical Characterization of Mast Cell Serine Proteases (Doctoral dissertation","author":"Karlson","year":"2003","journal-title":"Acta Universitatis Upsaliensis)"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100144_bib160","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1111\/j.1742-4658.2010.07642.x","article-title":"Arg143 and Lys192 of the human mast cell chymase mediate the preference for acidic amino acids in position P2\u2032 of substrates","volume":"277","author":"Andersson","year":"2010","journal-title":"FEBS Journal"},{"key":"10.1016\/j.pharmr.2026.100144_bib161","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejphar.2015.04.045","article-title":"Mast cell proteases as pharmacological targets","volume":"778","author":"Caughey","year":"2016","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100144_bib162","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/(SICI)1521-4141(199803)28:03<1022::AID-IMMU1022>3.0.CO;2-1","article-title":"Characterization of mouse mast cell protease-8, the first member of a novel subfamily of mouse mast cell serine proteases, distinct from both the classical chymases and tryptases","volume":"28","author":"L\u00fctzelschwab","year":"1998","journal-title":"Eur J Immunol"},{"issue":"5786","key":"10.1016\/j.pharmr.2026.100144_bib163","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1126\/science.1128877","article-title":"Mast cells can enhance resistance to snake and honeybee venoms","volume":"313","author":"Metz","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.pharmr.2026.100144_bib164","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.3389\/fimmu.2018.01532","article-title":"Human mast cell tryptase is a potential treatment for snakebite envenoming across multiple snake species","volume":"9","author":"Anderson","year":"2018","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100144_bib165","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.1172\/JCI46139","article-title":"Mast cell chymase reduces the toxicity of Gila monster venom, scorpion venom, and vasoactive intestinal polypeptide in mice","volume":"121","author":"Akahoshi","year":"2011","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100144_bib166","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s40629-020-00118-6","article-title":"Mast cells and IgE in defense against lethality of venoms: possible \u201cbenefit\u201d of allergy","volume":"29","author":"Galli","year":"2020","journal-title":"Allergo J Int"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100144_bib167","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/00001573-200207000-00009","article-title":"Dissecting the role of chymase in angiotensin II formation and heart and blood vessel diseases","volume":"17","author":"Dell\u2019Italia","year":"2002","journal-title":"Curr Opin Cardiol"},{"issue":"36","key":"10.1016\/j.pharmr.2026.100144_bib168","doi-asserted-by":"crossref","first-page":"22348","DOI":"10.1016\/S0021-9258(18)45712-2","article-title":"Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart","volume":"265","author":"Urata","year":"1990","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100144_bib169","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.jaci.2022.05.028","article-title":"Mast cell chymase regulates extracellular matrix remodeling-related events in primary human small airway epithelial cells","volume":"150","author":"Zhao","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"41","key":"10.1016\/j.pharmr.2026.100144_bib170","doi-asserted-by":"crossref","first-page":"25628","DOI":"10.1074\/jbc.272.41.25628","article-title":"Dog mast cell \u03b1-chymase activates progelatinase B by cleaving the Phe88\u2013Gln89 and Phe91\u2013Glu92 bonds of the catalytic domain","volume":"272","author":"Fang","year":"1997","journal-title":"J Biol Chem"},{"issue":"27","key":"10.1016\/j.pharmr.2026.100144_bib171","doi-asserted-by":"crossref","first-page":"18134","DOI":"10.1016\/S0021-9258(17)32427-4","article-title":"Activation of human interstitial procollagenase through direct cleavage of the Leu83\u2013Thr84 bond by mast cell chymase","volume":"269","author":"Saarinen","year":"1994","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100144_bib172","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1194\/jlr.M200420-JLR200","article-title":"Apolipoprotein composition and particle size affect HDL degradation by chymase: effect on cellular cholesterol efflux","volume":"44","author":"Lee","year":"2003","journal-title":"J Lipid Res"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100144_bib173","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/ki.2013.98","article-title":"Mast cell chymase protects against renal fibrosis in murine unilateral ureteral obstruction","volume":"84","author":"Beghdadi","year":"2013","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100144_bib174","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1161\/01.ATV.0000051405.68811.4D","article-title":"Mast cell chymase induces smooth muscle cell apoptosis by a mechanism involving fibronectin degradation and disruption of focal adhesions","volume":"23","author":"Leskinen","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100144_bib175","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jaci.2017.07.042","article-title":"Mast cell chymase decreases the severity of group B Streptococcus infections","volume":"142","author":"Gendrin","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100144_bib176","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.4049\/jimmunol.1601223","article-title":"Highly selective cleavage of cytokines and chemokines by the human mast cell chymase and neutrophil cathepsin G","volume":"198","author":"Fu","year":"2017","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100144_bib177","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1074\/jbc.M112.435156","article-title":"Mast cell chymase degrades the alarmins heat shock protein 70, biglycan, HMGB1, and interleukin-33 (IL-33) and limits danger-induced inflammation","volume":"289","author":"Roy","year":"2014","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100144_bib178","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.ajpath.2012.05.013","article-title":"The chymase mouse mast cell protease 4 degrades TNF, limits inflammation, and promotes survival in a model of sepsis","volume":"181","author":"Piliponsky","year":"2012","journal-title":"Am J Pathol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100144_bib179","doi-asserted-by":"crossref","first-page":"925","DOI":"10.3390\/cells9040925","article-title":"The chymase mouse mast cell protease-4 regulates intestinal cytokine expression in mature adult mice infected with Giardia intestinalis","volume":"9","author":"Li","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.pharmr.2026.100144_bib180","article-title":"Mast cell-derived chymases are essential for the resolution of inflammatory pain in mice","author":"de Souza","year":"2024","journal-title":"bioRxiv"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100144_bib181","doi-asserted-by":"crossref","first-page":"4689","DOI":"10.1074\/jbc.270.9.4689","article-title":"Human mast cell chymase and leukocyte elastase release latent transforming growth factor-\u03b21 from the extracellular matrix of cultured human epithelial and endothelial cells","volume":"270","author":"Taipale","year":"1995","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100144_bib182","doi-asserted-by":"crossref","first-page":"955","DOI":"10.3892\/etm.2015.2216","article-title":"High concentrations of mast cell chymase facilitate the transduction of the transforming growth factor-\u03b21\/Smads signaling pathway in skin fibroblasts","volume":"9","author":"Dong","year":"2015","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.pharmr.2026.100144_bib183","article-title":"The deficiency of chymase mast cell protease 4 exacerbates dextran sulfate sodium salt-induced colitis in mice and is associated with altered microbiota and metabolome profiles","volume":"15","author":"Li","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"issue":"13","key":"10.1016\/j.pharmr.2026.100144_bib184","doi-asserted-by":"crossref","first-page":"7761","DOI":"10.1073\/pnas.1231488100","article-title":"Mast cells disrupt epithelial barrier function during enteric nematode infection","volume":"100","author":"McDermott","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmr.2026.100144_bib185","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.801120","article-title":"Mast cell chymase\/Mcpt4 suppresses the host immune response to Plasmodium yoelii, limits malaria-associated disruption of intestinal barrier integrity and reduces parasite transmission to Anopheles stephensi","volume":"13","author":"C\u00e9spedes","year":"2022","journal-title":"Front Immunol"},{"issue":"52","key":"10.1016\/j.pharmr.2026.100144_bib186","doi-asserted-by":"crossref","first-page":"22381","DOI":"10.1073\/pnas.0906372106","article-title":"Mast cells regulate homeostatic intestinal epithelial migration and barrier function by a chymase\/Mcpt4-dependent mechanism","volume":"106","author":"Groschwitz","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100144_bib187","doi-asserted-by":"crossref","first-page":"G479","DOI":"10.1152\/ajpgi.00186.2012","article-title":"Chymase-mediated intestinal epithelial permeability is regulated by a protease-activating receptor\/matrix metalloproteinase-2-dependent mechanism","volume":"304","author":"Groschwitz","year":"2013","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100144_bib188","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.immuni.2024.04.020","article-title":"A new superhero, the intraepithelial mast cell, joins the \u201cGuardians of the Gut\u201d","volume":"57","author":"Zaini","year":"2024","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100144_bib189","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.immuni.2024.03.017","article-title":"Intraepithelial mast cells drive gasdermin C-mediated type 2 immunity","volume":"57","author":"Yang","year":"2024","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100144_bib190","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.3181\/0703-RM-85","article-title":"Chymase inhibition reduces the progression to heart failure after autoimmune myocarditis in rats","volume":"232","author":"Palaniyandi","year":"2007","journal-title":"Exp Biol Med"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100144_bib191","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1254\/jphs.09115FP","article-title":"Chymase inhibition provides pancreatic islet protection in hamsters with streptozotocin-induced diabetes","volume":"110","author":"Takai","year":"2009","journal-title":"J Pharmacol Sci"},{"issue":"20","key":"10.1016\/j.pharmr.2026.100144_bib192","doi-asserted-by":"crossref","first-page":"7495","DOI":"10.3390\/ijms21207495","article-title":"Mechanism of albuminuria reduction by chymase inhibition in diabetic mice","volume":"21","author":"Terai","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100144_bib193","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/01902148.2010.520815","article-title":"The specific chymase inhibitor TY-51469 suppresses the accumulation of neutrophils in the lung and reduces silica-induced pulmonary fibrosis in mice","volume":"37","author":"Takato","year":"2011","journal-title":"Exp Lung Res"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100144_bib194","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.3748\/wjg.v22.i5.1826","article-title":"Chymase inhibitor TY-51469 in therapy of inflammatory bowel disease","volume":"22","author":"Liu","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100144_bib195","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jphs.2017.04.005","article-title":"Chymase inhibitor prevents the development and progression of non-alcoholic steatohepatitis in rats fed a high-fat and high-cholesterol diet","volume":"134","author":"Miyaoka","year":"2017","journal-title":"J Pharmacol Sci"},{"issue":"18","key":"10.1016\/j.pharmr.2026.100144_bib196","doi-asserted-by":"crossref","first-page":"18001","DOI":"10.1074\/jbc.M501302200","article-title":"A novel, potent dual inhibitor of the leukocyte proteases cathepsin G and chymase","volume":"280","author":"de Garavilla","year":"2005","journal-title":"J Biol Chem"},{"issue":"15","key":"10.1016\/j.pharmr.2026.100144_bib197","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/S0024-3205(01)01255-3","article-title":"Oral administration of a specific chymase inhibitor, NK3201, inhibits vascular proliferation in grafted vein","volume":"69","author":"Takai","year":"2001","journal-title":"Life Sci"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100144_bib198","doi-asserted-by":"crossref","first-page":"6108","DOI":"10.1021\/acs.jmedchem.4c01819","article-title":"Discovery and preclinical characterization of Fulacimstat (BAY 1142524), a potent and selective chymase inhibitor as a new profibrinolytic approach for safe thrombus resolution","volume":"68","author":"F\u00fcrstner","year":"2025","journal-title":"J Med Chem"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100144_bib199","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1097\/HJH.0000000000000231","article-title":"Chymase inhibition improves vascular dysfunction and survival in stroke-prone spontaneously hypertensive rats","volume":"32","author":"Takai","year":"2014","journal-title":"J Hypertens"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100144_bib200","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.028056","article-title":"Chymase inhibition resolves and prevents deep vein thrombosis without increasing bleeding time in the mouse model","volume":"12","author":"Lapointe","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100144_bib201","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1254\/jphs.94.443","article-title":"A single treatment with a specific chymase inhibitor, TY-51184, prevents vascular proliferation in canine grafted veins","volume":"94","author":"Takai","year":"2004","journal-title":"J Pharmacol Sci"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100144_bib202","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1124\/jpet.103.061465","article-title":"An antiarrhythmic effect of a chymase inhibitor after myocardial infarction","volume":"309","author":"Jin","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"issue":"2\u20133","key":"10.1016\/j.pharmr.2026.100144_bib203","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ejphar.2003.11.009","article-title":"Significance of chymase inhibition for prevention of adhesion formation","volume":"484","author":"Okamoto","year":"2004","journal-title":"Eur J Pharmacol"},{"issue":"22","key":"10.1016\/j.pharmr.2026.100144_bib204","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1016\/j.bmcl.2003.08.040","article-title":"Structure-activity relationship of benzo[b]thiophene-2-sulfonamide derivatives as novel human chymase inhibitors","volume":"13","author":"Masaki","year":"2003","journal-title":"Bioorg Med Chem Lett"},{"issue":"1\u20133","key":"10.1016\/j.pharmr.2026.100144_bib205","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejphar.2004.04.024","article-title":"A specific chymase inhibitor, NK3201, suppresses bleomycin-induced pulmonary fibrosis in hamsters","volume":"493","author":"Sakaguchi","year":"2004","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100144_bib206","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0008-6363(02)00458-3","article-title":"Chymase inhibition suppresses high-cholesterol diet-induced lipid accumulation in the hamster aorta","volume":"55","author":"Uehara","year":"2002","journal-title":"Cardiovasc Res"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100144_bib207","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/01.LAB.0000018827.78602.F4","article-title":"Chymase participates in chronic dermatitis by inducing eosinophil infiltration","volume":"82","author":"Tomimori","year":"2002","journal-title":"Lab Investig"},{"issue":"2\u20133","key":"10.1016\/j.pharmr.2026.100144_bib208","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejphar.2003.08.050","article-title":"Involvement of mast cell chymase in bleomycin-induced pulmonary fibrosis in mice","volume":"478","author":"Tomimori","year":"2003","journal-title":"Eur J Pharmacol"},{"issue":"1\u20133","key":"10.1016\/j.pharmr.2026.100144_bib209","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ejphar.2008.10.040","article-title":"Oral chymase inhibitor SUN13834 ameliorates skin inflammation as well as pruritus in mouse model for atopic dermatitis","volume":"601","author":"Terakawa","year":"2008","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100144_bib210","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1254\/jjp.86.124","article-title":"An orally active chymase inhibitor, BCEAB, suppresses heart chymase activity in the hamster","volume":"86","author":"Takai","year":"2001","journal-title":"Jpn J Pharmacol"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100144_bib211","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1113\/EP087209","article-title":"Effects of the selective chymase inhibitor TEI-F00806 on the intrarenal renin-angiotensin system in salt-treated angiotensin I-infused hypertensive mice","volume":"103","author":"Ansary","year":"2018","journal-title":"Exp Physiol"},{"key":"10.1016\/j.pharmr.2026.100144_bib212","series-title":"Kelley\u2019s Textbook of Rheumatology","first-page":"232","year":"2013"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100144_bib213","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.iac.2018.04.003","article-title":"Hereditary alpha tryptasemia","volume":"38","author":"Lyons","year":"2018","journal-title":"Immunol Allergy Clin North Am"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100144_bib214","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114944","article-title":"A simple, sensitive and safe method to determine the human \u03b1\/\u03b2-tryptase genotype","volume":"9","author":"Le","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100144_bib215","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1111\/j.1742-4658.2006.05211.x","article-title":"Biology of mast cell tryptase. An inflammatory mediator","volume":"273","author":"Hallgren","year":"2006","journal-title":"FEBS Journal"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100144_bib216","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1165\/rcmb.2009-0324RT","article-title":"Mast cell peptidases","volume":"42","author":"Trivedi","year":"2010","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100144_bib217","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00251-010-0443-2","article-title":"High degree of conservation of the multigene tryptase locus over the past 150\u2013200 million years of mammalian evolution","volume":"62","author":"Reimer","year":"2010","journal-title":"Immunogenetics"},{"issue":"37","key":"10.1016\/j.pharmr.2026.100144_bib218","doi-asserted-by":"crossref","first-page":"34941","DOI":"10.1074\/jbc.M102997200","article-title":"Definition of the extended substrate specificity determinants for \u03b2-tryptases I and II","volume":"276","author":"Harris","year":"2001","journal-title":"J Biol Chem"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100144_bib219","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.110739","article-title":"Computational modeling of mast cell tryptase family informs selective inhibitor development","volume":"27","author":"Ma","year":"2024","journal-title":"iScience"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100144_bib220","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1172\/JCI118523","article-title":"A novel heparin-dependent processing pathway for human tryptase. Autocatalysis followed by activation with dipeptidyl peptidase I","volume":"97","author":"Sakai","year":"1996","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100144_bib221","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s10719-016-9749-0","article-title":"Mast cell glycosaminoglycans","volume":"34","author":"Mulloy","year":"2017","journal-title":"Glycoconj J"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100144_bib222","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1600-065X.2007.00525.x","article-title":"Protease-proteoglycan complexes of mouse and human mast cells and importance of their \u03b2-tryptase-heparin complexes in inflammation and innate immunity","volume":"217","author":"Stevens","year":"2007","journal-title":"Immunol Rev"},{"issue":"6673","key":"10.1016\/j.pharmr.2026.100144_bib223","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/32703","article-title":"Human \u03b2-tryptase is a ring-like tetramer with active sites facing a central pore","volume":"392","author":"Pereira","year":"1998","journal-title":"Nature"},{"issue":"20","key":"10.1016\/j.pharmr.2026.100144_bib224","doi-asserted-by":"crossref","first-page":"10984","DOI":"10.1073\/pnas.96.20.10984","article-title":"The structure of the human \u03b2II-tryptase tetramer: fo(u)r better or worse","volume":"96","author":"Sommerhoff","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"issue":"33","key":"10.1016\/j.pharmr.2026.100144_bib225","doi-asserted-by":"crossref","first-page":"10757","DOI":"10.1021\/bi049486c","article-title":"Human \u03b2-tryptase: detection and characterization of the active monomer and prevention of tetramer reconstitution by protease inhibitors","volume":"43","author":"Fukuoka","year":"2004","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100144_bib226","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.jmb.2007.03.011","article-title":"A tick protein with a modified Kunitz fold inhibits human tryptase","volume":"368","author":"Paesen","year":"2007","journal-title":"J Mol Biol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100144_bib227","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1432-1033.1996.00619.x","article-title":"Purification, characterization and biological evaluation of recombinant leech-derived tryptase inhibitor (rLDTI) expressed at high level in the yeast Saccharomyces cerevisiae","volume":"241","author":"Pohlig","year":"1996","journal-title":"Eur J Biochem"},{"issue":"17","key":"10.1016\/j.pharmr.2026.100144_bib228","doi-asserted-by":"crossref","first-page":"6732","DOI":"10.1021\/jm4005362","article-title":"Therapeutic potential of the peptide leucine arginine as a new nonplant bowman-birk-like serine protease inhibitor","volume":"56","author":"Rothemund","year":"2013","journal-title":"J Med Chem"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100144_bib229","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1021\/np010304e","article-title":"Cyclotheonamide E4 and E5, new potent tryptase inhibitors from an Ircinia species of sponge","volume":"65","author":"Murakami","year":"2002","journal-title":"J Nat Prod"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100144_bib230","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jmb.2009.10.028","article-title":"Engineered cystine knot miniproteins as potent inhibitors of human mast cell tryptase \u03b2","volume":"395","author":"Sommerhoff","year":"2010","journal-title":"J Mol Biol"},{"issue":"20","key":"10.1016\/j.pharmr.2026.100144_bib231","doi-asserted-by":"crossref","first-page":"6197","DOI":"10.1021\/jm901233u","article-title":"Potent inhibitors of \u03b2-tryptase and human leukocyte elastase based on the MCoTI-II scaffold","volume":"52","author":"Thongyoo","year":"2009","journal-title":"J Med Chem"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100144_bib232","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.4049\/jimmunol.173.3.1868","article-title":"Histidines are critical for heparin-dependent activation of mast cell tryptase","volume":"173","author":"Hallgren","year":"2004","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100144_bib233","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1039\/C4MB00381K","article-title":"Heparin makes differences: a molecular dynamics simulation study on the human \u03b2II-tryptase monomer","volume":"11","author":"Wang","year":"2015","journal-title":"Mol Biosyst"},{"issue":"25","key":"10.1016\/j.pharmr.2026.100144_bib234","doi-asserted-by":"crossref","first-page":"9614","DOI":"10.1074\/jbc.M117.812016","article-title":"Dual functionality of \u03b2-tryptase protomers as both proteases and cofactors in the active tetramer","volume":"293","author":"Maun","year":"2018","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100144_bib235","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1021\/ar50123a006","article-title":"Structural basis of the activation and action of trypsin","volume":"11","author":"Huber","year":"1978","journal-title":"Acc Chem Res"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100144_bib236","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1021\/cr000033x","article-title":"Serine protease mechanism and specificity","volume":"102","author":"Hedstrom","year":"2002","journal-title":"Chem Rev"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100144_bib237","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/pro.5560070401","article-title":"Molecular mechanisms for the conversion of zymogens to active proteolytic enzymes","volume":"7","author":"Khan","year":"1998","journal-title":"Protein Sci"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100144_bib238","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/0092-8674(88)90567-3","article-title":"The molecular basis of blood coagulation","volume":"53","author":"Furie","year":"1988","journal-title":"Cell"},{"issue":"42","key":"10.1016\/j.pharmr.2026.100144_bib239","doi-asserted-by":"crossref","first-page":"13511","DOI":"10.1021\/bi960042t","article-title":"Inactivation of human lung tryptase: evidence for a re-activatable tetrameric intermediate and active monomers","volume":"35","author":"Addington","year":"1996","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100144_bib240","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1042\/bj20021418","article-title":"Formation of active monomers from tetrameric human \u03b2-tryptase","volume":"369","author":"Fajardo","year":"2003","journal-title":"Biochem J"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100144_bib241","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0022-2836(02)00625-3","article-title":"The crystal structure of human \u03b11-tryptase reveals a blocked substrate-binding region","volume":"321","author":"Marquardt","year":"2002","journal-title":"J Mol Biol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100144_bib242","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jmb.2005.12.037","article-title":"X-ray structures of free and leupeptin-complexed human \u03b1I-tryptase mutants: indication for an \u03b1\u2192 \u03b2-tryptase transition","volume":"357","author":"Rohr","year":"2006","journal-title":"J Mol Biol"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100144_bib243","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1084\/jem.20190701","article-title":"Impact of naturally forming human \u03b1\/\u03b2-tryptase heterotetramers in the pathogenesis of hereditary \u03b1-tryptasemia","volume":"216","author":"Le","year":"2019","journal-title":"J Exp Med"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100144_bib244","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/ng.3696","article-title":"Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number","volume":"48","author":"Lyons","year":"2016","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100144_bib245","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.iac.2023.04.006","article-title":"Update on mast cell proteases as drug targets","volume":"43","author":"Caughey","year":"2023","journal-title":"Immunol Allergy Clin North Am"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100144_bib246","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2174\/138161280405221010161920","article-title":"Inhibitors of tryptase for the treatment of mast cell-mediated diseases","volume":"4","author":"Rice","year":"1998","journal-title":"Curr Pharm Des"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100144_bib247","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1067\/mai.2001.115631","article-title":"Inhibition of mast cell tryptase by inhaled APC 366 attenuates allergen-induced late-phase airway obstruction in asthma","volume":"107","author":"Krishna","year":"2001","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100144_bib248","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1046\/j.1365-2036.2002.01194.x","article-title":"Treatment of mildly to moderately active ulcerative colitis with a tryptase inhibitor (APC 2059): an open-label pilot study","volume":"16","author":"Tremaine","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100144_bib249","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1365-2222.2006.02474.x","article-title":"Effects of a reversible \u03b2-tryptase and trypsin inhibitor (RWJ-58643) on nasal allergic responses","volume":"36","author":"Erin","year":"2006","journal-title":"Clin Experimental Allergy"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100144_bib250","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pupt.2004.09.032","article-title":"Inhibitors of mast cell tryptase beta as therapeutics for the treatment of asthma and inflammatory disorders","volume":"18","author":"Cairns","year":"2005","journal-title":"Pulm Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100144_bib251","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1016\/j.bmcl.2008.01.093","article-title":"Potent, nonpeptide inhibitors of human mast cell tryptase. Synthesis and biological evaluation of novel spirocyclic piperidine amide derivatives","volume":"18","author":"Costanzo","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100144_bib252","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1080\/13543776.2017.1322064","article-title":"Tryptase inhibitors: a patent review","volume":"27","author":"Ni","year":"2017","journal-title":"Expert Opin Ther Pat"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100144_bib253","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.4049\/jimmunol.168.4.1992","article-title":"Tryptase inhibition blocks airway inflammation in a mouse asthma model","volume":"168","author":"Oh","year":"2002","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100144_bib254","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/S0006-2952(99)00304-4","article-title":"Inhibition of allergen-induced pulmonary responses by the selective tryptase inhibitor 1,5-bis-[4-[(3-carbamimidoyl-benzenesulfonylamino)-methyl]-phenoxy","volume":"58","author":"Wright","year":"1999","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100144_bib255","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1021\/acs.jmedchem.9b01689","article-title":"Novel, self-assembling dimeric inhibitors of human \u03b2 tryptase","volume":"63","author":"Giardina","year":"2020","journal-title":"J Med Chem"},{"issue":"20","key":"10.1016\/j.pharmr.2026.100144_bib256","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1016\/S0960-894X(00)00485-6","article-title":"Dibasic inhibitors of human mast cell tryptase. Part 2: structure-activity relationships and requirements for potent activity","volume":"10","author":"Rice","year":"2000","journal-title":"Bioorg Med Chem Lett"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100144_bib257","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0960-894X(02)00063-X","article-title":"Bivalent inhibition of \u03b2-tryptase: distance scan of neighboring subunits by dibasic inhibitors","volume":"12","author":"Schaschke","year":"2002","journal-title":"Bioorg Med Chem Lett"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100144_bib258","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1074-5521(01)00011-4","article-title":"Bivalent inhibition of human \u03b2-tryptase","volume":"8","author":"Schaschke","year":"2001","journal-title":"Chem Biol"},{"issue":"24","key":"10.1016\/j.pharmr.2026.100144_bib259","doi-asserted-by":"crossref","first-page":"6053","DOI":"10.1016\/j.bmcl.2004.09.065","article-title":"Design of bivalent ligands using hydrogen bond linkers: synthesis and evaluation of inhibitors for human \u03b2-tryptase","volume":"14","author":"Vaz","year":"2004","journal-title":"Bioorg Med Chem Lett"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100144_bib260","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.4049\/jimmunol.176.5.3165","article-title":"The B12 anti-tryptase monoclonal antibody disrupts the tetrameric structure of heparin-stabilized \u03b2-tryptase to form monomers that are inactive at neutral pH and active at acidic pH","volume":"176","author":"Fukuoka","year":"2006","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100144_bib261","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cell.2019.09.009","article-title":"An allosteric anti-tryptase antibody for the treatment of mast cell-mediated severe asthma","volume":"179","author":"Maun","year":"2019","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100144_bib262","doi-asserted-by":"crossref","first-page":"6435","DOI":"10.1038\/s41467-020-20143-x","article-title":"Bivalent antibody pliers inhibit \u03b2-tryptase by an allosteric mechanism dependent on the IgG hinge","volume":"11","author":"Maun","year":"2020","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100144_bib263","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1038\/s41467-026-70491-3","article-title":"Complete inhibition of \u03b2-tryptase by tetramer dissociation and active site allostery due to a single antibody residue","volume":"17","author":"Maun","year":"2026","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100144_bib264","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/cts.13163","article-title":"Dose-dependent inactivation of airway tryptase with a novel dissociating anti-tryptase antibody (MTPS9579A) in healthy participants: a randomized trial","volume":"15","author":"Rymut","year":"2022","journal-title":"Clin Transl Sci"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100144_bib265","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1111\/all.16309","article-title":"Airway tryptase levels inform the lack of clinical efficacy of the tryptase inhibitor MTPS9579A in asthma","volume":"79","author":"Rhee","year":"2024","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100144_bib266","doi-asserted-by":"crossref","first-page":"647","DOI":"10.4049\/jimmunol.182.1.647","article-title":"Mast cells contribute to autoimmune inflammatory arthritis via their tryptase\/heparin complexes","volume":"182","author":"Shin","year":"2009","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100144_bib267","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1073\/pnas.1005758108","article-title":"Essential role for mast cell tryptase in acute experimental colitis","volume":"108","author":"Hamilton","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100144_bib268","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jaci.2012.11.053","article-title":"A new short-term mouse model of chronic obstructive pulmonary disease identifies a role for mast cell tryptase in pathogenesis","volume":"131","author":"Beckett","year":"2013","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100144_bib269","doi-asserted-by":"crossref","first-page":"4783","DOI":"10.4049\/jimmunol.1302947","article-title":"Mouse mast cell protease-6 and MHC are involved in the development of experimental asthma","volume":"193","author":"Cui","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmr.2026.100144_bib270","doi-asserted-by":"crossref","DOI":"10.3389\/fpain.2021.805136","article-title":"mMCP7, a mouse ortholog of \u03b4 tryptase, Mediates pelvic tactile allodynia in a model of chronic pelvic pain","volume":"2","author":"Pattabiraman","year":"2022","journal-title":"Front Pain Res"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100144_bib271","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1074\/jbc.271.5.2851","article-title":"Natural disruption of the mouse mast cell protease 7 gene in the C57BL\/6 mouse","volume":"271","author":"Hunt","year":"1996","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100144_bib272","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1161\/CIRCRESAHA.111.243758","article-title":"Mast cell tryptase deficiency attenuates mouse abdominal aortic aneurysm formation","volume":"108","author":"Zhang","year":"2011","journal-title":"Circ Res"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100144_bib273","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.3390\/cells8101190","article-title":"The absence of tryptase Mcpt6 causes elevated cellular stress in response to modulation of the histone acetylation status in mast cells","volume":"8","author":"Santosh Martin","year":"2019","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100144_bib274","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/mi.2014.131","article-title":"Potential effector and immunoregulatory functions of mast cells in mucosal immunity","volume":"8","author":"Reber","year":"2015","journal-title":"Mucosal Immunol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100144_bib275","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/jcb.240500402","article-title":"Pericellulars substrates of human mast cell tryptase: 72,000 dalton gelatinase and fibronectin","volume":"50","author":"Lohi","year":"1992","journal-title":"J Cell Biochem"},{"issue":"46","key":"10.1016\/j.pharmr.2026.100144_bib276","doi-asserted-by":"crossref","first-page":"42774","DOI":"10.1074\/jbc.M105531200","article-title":"Structural requirements and mechanism for heparin-induced activation of a recombinant mouse mast cell tryptase, mouse mast cell protease-6","volume":"276","author":"Hallgren","year":"2001","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100144_bib277","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12964-018-0269-3","article-title":"Mast cells and mast cell tryptase enhance migration of human lung fibroblasts through protease-activated receptor 2","volume":"16","author":"Bagher","year":"2018","journal-title":"Cell Commun Signal"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100144_bib278","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.4049\/jimmunol.160.4.1910","article-title":"Induction of a selective and persistent extravasation of neutrophils into the peritoneal cavity by tryptase mouse mast cell protease 6","volume":"160","author":"Huang","year":"1998","journal-title":"J Immunol"},{"issue":"42","key":"10.1016\/j.pharmr.2026.100144_bib279","doi-asserted-by":"crossref","first-page":"13068","DOI":"10.1021\/bi000973b","article-title":"Mechanism for activation of mouse mast cell tryptase: dependence on heparin and acidic pH for formation of active tetramers of mouse mast cell protease 6","volume":"39","author":"Hallgren","year":"2000","journal-title":"Biochemistry"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100144_bib280","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1161\/01.ATV.0000174797.71708.97","article-title":"Mast cell tryptase in mast cell granules enhances MCP-1 and interleukin-8 production in human endothelial cells","volume":"25","author":"Kinoshita","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100144_bib281","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jaci.2024.02.011","article-title":"Airway hyperresponsiveness in asthma: the role of the epithelium","volume":"153","author":"Bradding","year":"2024","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100144_bib282","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s12974-018-1287-1","article-title":"Effect of tryptase on mouse brain microvascular endothelial cells via protease-activated receptor 2","volume":"15","author":"Zhou","year":"2018","journal-title":"J Neuroinflammation"},{"issue":"28","key":"10.1016\/j.pharmr.2026.100144_bib283","doi-asserted-by":"crossref","first-page":"26276","DOI":"10.1074\/jbc.M102356200","article-title":"Evaluation of the substrate specificity of human mast cell tryptase beta I and demonstration of its importance in bacterial infections of the lung","volume":"276","author":"Huang","year":"2001","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100144_bib284","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.4049\/jimmunol.180.7.4885","article-title":"Mouse mast cell tryptase mMCP-6 is a critical link between adaptive and innate immunity in the chronic phase of Trichinella spiralis infection","volume":"180","author":"Shin","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmr.2026.100144_bib285","series-title":"Mast Cell Biology","first-page":"212","article-title":"Mast cell proteases as protective and inflammatory mediators","author":"Caughey","year":"2011"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100144_bib286","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.3390\/cells12101439","article-title":"Mast cell tryptase promotes airway remodeling by inducing anti-apoptotic and cell growth properties in human alveolar and bronchial epithelial cells","volume":"12","author":"Berlin","year":"2023","journal-title":"Cells"},{"issue":"suppl 2","key":"10.1016\/j.pharmr.2026.100144_bib287","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1164\/ajrccm.164.supplement_2.2106058","article-title":"Mast cell tryptases and airway remodeling","volume":"164","author":"Sommerhoff","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"24","key":"10.1016\/j.pharmr.2026.100144_bib288","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.3390\/diagnostics13243662","article-title":"Diagnostic significance of tryptase for suspected mast cell disorders","volume":"13","author":"Beyens","year":"2023","journal-title":"Diagnostics"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100144_bib289","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1016\/j.jaip.2022.06.028","article-title":"Elevated tryptase: conditions and pitfalls","volume":"10","author":"Pongdee","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100144_bib290","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1016\/j.jaip.2024.08.044","article-title":"Harmonization of diagnostic criteria in mastocytosis for use in clinical practice: WHO vs ICC vs AIM\/ECNM","volume":"12","author":"Valent","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100144_bib291","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.anai.2025.03.003","article-title":"What the clinician should know when ordering a mast cell tryptase test","volume":"134","author":"Michel","year":"2025","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100144_bib292","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.3390\/ijms22052458","article-title":"Genetic regulation of tryptase production and clinical impact: hereditary alpha tryptasemia, mastocytosis and beyond","volume":"22","author":"Sprinzl","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100144_bib293","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1021\/bi972119z","article-title":"Human mast cell tryptase fibrinogenolysis: kinetics, anticoagulation mechanism, and cell adhesion disruption","volume":"37","author":"Thomas","year":"1998","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100144_bib294","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.iac.2018.04.011","article-title":"Mast cell mediators of significance in clinical practice in mastocytosis","volume":"38","author":"Butterfield","year":"2018","journal-title":"Immunol Allergy Clin North Am"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100144_bib295","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1159\/000520972","article-title":"Mast cell tryptase potentiates neutrophil extracellular trap formation","volume":"14","author":"Pejler","year":"2022","journal-title":"J Innate Immun"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100144_bib296","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0014-2999(97)83033-6","article-title":"Human mast cell tryptase: a stimulus of microvascular leakage and mast cell activation","volume":"328","author":"He","year":"1997","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100144_bib297","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1182\/blood-2007-07-104018","article-title":"Phagocytosis-independent antimicrobial activity of mast cells by means of extracellular trap formation","volume":"111","author":"von K\u00f6ckritz-Blickwede","year":"2008","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100144_bib298","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.bbrc.2019.08.098","article-title":"Mast cell peptidases (carboxypeptidase a and chymase)-mediated hydrolysis of human angiotensin-(1\u201312) substrate","volume":"518","author":"Ahmad","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100144_bib299","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1021\/acschembio.5c00791","article-title":"Structure-activity relationships of Anabaenopeptins as carboxypeptidase and phosphatase inhibitors","volume":"21","author":"Quandt","year":"2026","journal-title":"ACS Chem Biol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100144_bib300","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1172\/JCI114061","article-title":"Human mast cell carboxypeptidase. Purification and characterization","volume":"83","author":"Goldstein","year":"1989","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100144_bib301","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.it.2009.04.008","article-title":"Novel insights into the biological function of mast cell carboxypeptidase A","volume":"30","author":"Pejler","year":"2009","journal-title":"Trends Immunol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100144_bib302","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3390\/cells11030570","article-title":"Carboxypeptidase A3-A key component of the protease phenotype of mast cells","volume":"11","author":"Atiakshin","year":"2022","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100144_bib303","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1177\/03009858211062636","article-title":"Carboxypeptidase A3 expression in canine mast cell tumors and tissue-resident mast cells","volume":"59","author":"H\u00e4m\u00e4l\u00e4inen","year":"2022","journal-title":"Vet Pathol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100144_bib304","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0300668","article-title":"Disruption of the mast cell carboxypeptidase A3 gene does not attenuate airway inflammation and hyperresponsiveness in two mouse models of asthma","volume":"19","author":"Waern","year":"2024","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100144_bib305","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s00011-025-02046-z","article-title":"Targeting carboxypeptidase A\/B activity with the phosphinic inhibitor C28 reduces the asthmatic response in a mouse model of house dust mite-induced asthma","volume":"74","author":"Allam","year":"2025","journal-title":"Inflamm Res"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100144_bib306","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12974-020-01795-4","article-title":"Mouse connective tissue mast cell proteases tryptase and carboxypeptidase A3 play protective roles in itch induced by endothelin-1","volume":"17","author":"Magn\u00fasd\u00f3ttir","year":"2020","journal-title":"J Neuroinflammation"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100144_bib307","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1084\/jem.20071262","article-title":"Molecular mechanism of mast cell mediated innate defense against endothelin and snake venom sarafotoxin","volume":"204","author":"Schneider","year":"2007","journal-title":"J Exp Med"},{"issue":"31","key":"10.1016\/j.pharmr.2026.100144_bib308","doi-asserted-by":"crossref","first-page":"32339","DOI":"10.1074\/jbc.M405576200","article-title":"Cooperation between mast cell carboxypeptidase A and the chymase mouse mast cell protease 4 in the formation and degradation of angiotensin II","volume":"279","author":"Lundequist","year":"2004","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100144_bib309","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.jaci.2007.05.001","article-title":"Risk assessment in anaphylaxis: current and future approaches","volume":"120","author":"Simons","year":"2007","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100144_bib310","first-page":"814","article-title":"[Measurement of plasma mast cell carboxypeptidase and chymase levels in children with allergic diseases]","volume":"13","author":"Pan","year":"2011","journal-title":"Zhong Guo Dang Dai Er Ke Za Zhi"},{"key":"10.1016\/j.pharmr.2026.100144_bib311","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40413-016-0094-3","article-title":"Biomarkers of the involvement of mast cells, basophils and eosinophils in asthma and allergic diseases","volume":"9","author":"Metcalfe","year":"2016","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.pharmr.2026.100144_bib312","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.924244","article-title":"Dynamically upregulated mast cell CPA3 patterns in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis","volume":"13","author":"Siddhuraj","year":"2022","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100144_bib313","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/JLB.4HI0221-087R","article-title":"Severe COVID-19 is marked by dysregulated serum levels of carboxypeptidase A3 and serotonin","volume":"110","author":"Soria-Castro","year":"2021","journal-title":"J Leukoc Biol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100144_bib314","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s13048-024-01516-y","article-title":"Neoadjuvant chemotherapy induces phenotypic mast cell changes in high grade serous ovarian cancer","volume":"17","author":"McAdams","year":"2024","journal-title":"J Ovarian Res"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100144_bib315","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/j.jaip.2024.03.010","article-title":"Detecting changes in mast cell numbers versus activation in human disease: a roadblock for current biomarkers?","volume":"12","author":"Akin","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100144_bib316","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.jaci.2010.03.003","article-title":"Accumulation of intraepithelial mast cells with a unique protease phenotype in TH2-high asthma","volume":"125","author":"Dougherty","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.pharmr.2026.100144_bib317","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117281","article-title":"Lactobacillus casei ATCC 393 alleviates enterotoxigenic Escherichia coli K88-induced intestinal barrier dysfunction via TLRs\/mast cells pathway","volume":"244","author":"Xu","year":"2020","journal-title":"Life Sci"},{"issue":"6294","key":"10.1016\/j.pharmr.2026.100144_bib318","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/347667a0","article-title":"Embryonic expression of a haematopoietic growth factor encoded by the SI locus and the ligand for c-kit","volume":"347","author":"Matsui","year":"1990","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100144_bib319","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.immuni.2011.11.004","article-title":"Mast cell deficiency, a game of kit and mouse","volume":"35","author":"Katz","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.pharmr.2026.100144_bib320","series-title":"c-Kit Gene Was Not Transcribed in Cultured Mast Cells of Mast Cell-Deficient Wsh\/Wsh Mice That Have a Normal Number of Erythrocytes and a Normal c-Kit Coding Region","author":"Tono","year":"1992"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100144_bib321","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/ni.f.216","article-title":"New developments in mast cell biology","volume":"9","author":"Kalesnikoff","year":"2008","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100144_bib322","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.immuni.2008.10.016","article-title":"Deletion of Notch1 converts pro-T cells to dendritic cells and promotes thymic B cells by cell-extrinsic and cell-intrinsic mechanisms","volume":"30","author":"Feyerabend","year":"2009","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100144_bib323","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11248-007-9153-4","article-title":"Mast cell-specific Cre\/loxP-mediated recombination in vivo","volume":"17","author":"Scholten","year":"2008","journal-title":"Transgen Res"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100144_bib324","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-2222.2007.02886.x","article-title":"The mast cell and allergic diseases: role in pathogenesis and implications for therapy","volume":"38","author":"Brown","year":"2008","journal-title":"Clin Experimental Allergy"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100144_bib325","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-2466-9-27","article-title":"Stem cell factor and its soluble receptor (c-kit) in serum of asthmatic patients- correlation with disease severity","volume":"9","author":"Makowska","year":"2009","journal-title":"BMC Pulm Med"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100144_bib326","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.it.2017.10.005","article-title":"Mast cells as drivers of disease and therapeutic targets","volume":"39","author":"Siebenhaar","year":"2018","journal-title":"Trends Immunol"},{"issue":"20","key":"10.1016\/j.pharmr.2026.100144_bib327","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1056\/NEJMoa1613125","article-title":"KIT inhibition by imatinib in patients with severe refractory asthma","volume":"376","author":"Cahill","year":"2017","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100144_bib328","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.leukres.2011.05.006","article-title":"Tyrosine kinase inhibitors in the treatment of systemic mastocytosis","volume":"35","author":"Ustun","year":"2011","journal-title":"Leuk Res"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100144_bib329","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.jaci.2014.03.007","article-title":"Molecular targets on mast cells and basophils for novel therapies","volume":"134","author":"Harvima","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100144_bib330","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.coi.2009.09.010","article-title":"Are we ready to downregulate mast cells?","volume":"21","author":"Karra","year":"2009","journal-title":"Curr Opin Immunol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100144_bib331","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nrc.2017.28","article-title":"Exploring the TRAILs less travelled: TRAIL in cancer biology and therapy","volume":"17","author":"von Karstedt","year":"2017","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100144_bib332","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.4049\/jimmunol.176.4.2272","article-title":"Human mast cells undergo TRAIL-induced apoptosis","volume":"176","author":"Berent-Maoz","year":"2006","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100144_bib333","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.4049\/jimmunol.0903656","article-title":"The BH3-mimetic ABT-737 induces mast cell apoptosis in vitro and in vivo: potential for therapeutics","volume":"185","author":"Karlberg","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmr.2026.100144_bib334","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3389\/fped.2016.00135","article-title":"Killing two cells with one stone: pharmacologic BCL-2 family targeting for cancer cell death and immune modulation","volume":"4","author":"Ludwig","year":"2016","journal-title":"Front Pediatr"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100144_bib335","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/cdd.2017.154","article-title":"BH3 mimetics efficiently induce apoptosis in mouse basophils and mast cells","volume":"25","author":"Reinhart","year":"2018","journal-title":"Cell Death Differ"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100144_bib336","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.1074\/jbc.M110.176461","article-title":"A role for serglycin proteoglycan in mast cell apoptosis induced by a secretory granule-mediated pathway","volume":"286","author":"Melo","year":"2011","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100144_bib337","doi-asserted-by":"crossref","first-page":"487","DOI":"10.4161\/auto.5774","article-title":"Anti-cancer agent siramesine is a lysosomotropic detergent that induces cytoprotective autophagosome accumulation","volume":"4","author":"Ostenfeld","year":"2008","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100144_bib338","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/bjd.15336","article-title":"Siramesine causes preferential apoptosis of mast cells in skin biopsies from psoriatic lesions","volume":"177","author":"Hagforsen","year":"2017","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100144_bib339","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.66","article-title":"Mefloquine, an anti-malaria agent, causes reactive oxygen species-dependent cell death in mast cells via a secretory granule-mediated pathway","volume":"2","author":"Paivandy","year":"2014","journal-title":"Pharmacol Res Perspect"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100144_bib340","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41420-019-0177-3","article-title":"Lysosomotropic challenge of mast cells causes intra-granular reactive oxygen species production","volume":"5","author":"Paivandy","year":"2019","journal-title":"Cell Death Discov"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100144_bib341","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.jaci.2020.11.005","article-title":"A randomized double-blind, placebo-controlled study of omalizumab for idiopathic anaphylaxis","volume":"147","author":"Carter","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100144_bib342","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.anai.2023.07.019","article-title":"Evidence-based use of antihistamines for treatment of allergic conditions","volume":"131","author":"Linton","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100144_bib343","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/ajh.26962","article-title":"Systemic mastocytosis in adults: 2023 update on diagnosis, risk stratification and management","volume":"98","author":"Pardanani","year":"2023","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100144_bib344","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.pharmthera.2012.06.005","article-title":"Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions","volume":"135","author":"Kiwamoto","year":"2012","journal-title":"Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100144_bib345","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/cells10010019","article-title":"Discovery, function, and therapeutic targeting of Siglec-8","volume":"10","author":"Youngblood","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.pharmr.2026.100144_bib346","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.833728","article-title":"The inhibitory receptor Siglec-8 interacts with Fc\u03b5RI and globally inhibits intracellular signaling in primary mast cells upon activation","volume":"13","author":"Korver","year":"2022","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100144_bib347","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.pharmthera.2014.01.004","article-title":"Targeting mast cells in inflammatory diseases","volume":"142","author":"Reber","year":"2014","journal-title":"Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100144_bib348","article-title":"Inhaled corticosteroids versus sodium cromoglycate in children and adults with asthma","volume":"2009","author":"Guevara","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pharmr.2026.100144_bib349","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3389\/fphar.2017.00827","article-title":"The anti-allergic Cromones: past, present, and future","volume":"8","author":"Sinniah","year":"2017","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100144_bib350","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ceca.2019.01.003","article-title":"CRAC channel regulation of innate immune cells in health and disease","volume":"78","author":"Clemens","year":"2019","journal-title":"Cell Calcium"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100144_bib351","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/cea.12675","article-title":"Mast cells in asthma\u2014state of the art","volume":"46","author":"Bradding","year":"2016","journal-title":"Clin Experimental Allergy"},{"key":"10.1016\/j.pharmr.2026.100144_bib352","series-title":"Biologics in Allergic\/Immunologic Conditions, an Issue of Immunology and Allergy Clinics of North America: Biologics in Allergic\/Immunologic Conditions, an Issue of Immunology and Allergy Clinics of North America","author":"Hoyte","year":"2024"},{"key":"10.1016\/j.pharmr.2026.100144_bib353","series-title":"Immunobiology: the Immune System in Health and Disease","article-title":"The components of the immune system","author":"Janeway","year":"2001"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100144_bib354","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/imr.12636","article-title":"Is it time for a new classification of mast cells? What do we know about mast cell heterogeneity?","volume":"282","author":"Frossi","year":"2018","journal-title":"Immunol Rev"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100144_bib355","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/imcb.12768","article-title":"Highlight of 2023: advances in mast cells","volume":"102","author":"Barra","year":"2024","journal-title":"Immunol Cell Biol"},{"issue":"18","key":"10.1016\/j.pharmr.2026.100144_bib356","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1182\/blood-2009-08-237206","article-title":"Human embryonic stem cells: a source of mast cells for the study of allergic and inflammatory diseases","volume":"115","author":"Kovarova","year":"2010","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100144_bib357","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1189\/jlb.0712354","article-title":"Molecular and stimulus-response profiles illustrate heterogeneity between peripheral and cord blood-derived human mast cells","volume":"95","author":"Jensen","year":"2014","journal-title":"J Leukoc Biol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100144_bib358","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.jaci.2021.12.788","article-title":"In vitro models of human mast cells: how to get more and better with induced pluripotent stem cells?","volume":"149","author":"L\u2019homme","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100144_bib359","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/cea.14487","article-title":"Mast cell versus basophil activation test in allergy: current status","volume":"54","author":"Ebo","year":"2024","journal-title":"Clin Experimental Allergy"},{"key":"10.1016\/j.pharmr.2026.100144_bib360","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.3389\/fimmu.2018.02193","article-title":"An optimized protocol for the isolation and functional analysis of human lung mast cells","volume":"9","author":"Ravindran","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.pharmr.2026.100144_bib361","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/978-1-0716-0648-3_4","article-title":"Isolation and culture of human skin mast cells","volume":"2154","author":"Siiskonen","year":"2020","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.pharmr.2026.100144_bib362","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.3389\/fimmu.2019.01445","article-title":"Human skin-derived mast cells spontaneously secrete several angiogenesis-related factors","volume":"10","author":"McHale","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.pharmr.2026.100144_bib363","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.im0725s90","article-title":"Isolation of tissue mast cells","author":"Kulka","year":"2010","journal-title":"Curr Protoc Immunol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100144_bib364","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/s41596-019-0288-6","article-title":"Rapid identification of human mast cell degranulation regulators using functional genomics coupled to high-resolution confocal microscopy","volume":"15","author":"Folkerts","year":"2020","journal-title":"Nat Protoc"},{"key":"10.1016\/j.pharmr.2026.100144_bib365","first-page":"113","article-title":"Culture of human mast cells from hemopoietic progenitors","volume":"315","author":"Saito","year":"2006","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.pharmr.2026.100144_bib366","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2021.113003","article-title":"Peripheral blood cultured mast cells: phenotypic and functional outcomes of different culture protocols","volume":"492","author":"Elst","year":"2021","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.pharmr.2026.100144_bib367","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2021.113061","article-title":"Culturing cells with mast cell phenotype and function: comparison of peripheral blood and bone marrow as a source","volume":"495","author":"Elst","year":"2021","journal-title":"J Immunol Methods"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100144_bib368","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jaci.2024.11.023","article-title":"Flow cytometry\u2013based basophil and mast cell activation tests in allergology: state of the art","volume":"155","author":"Ebo","year":"2025","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100144_bib369","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.jaci.2021.07.027","article-title":"A novel approach for studying mast cell\u2013driven disorders: mast cells derived from induced pluripotent stem cells","volume":"149","author":"Luo","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100144_bib370","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1164\/ajrccm.161.5.9908090","article-title":"Increased numbers of both airway basophils and mast cells in sputum after allergen inhalation challenge of atopic asthmatics","volume":"161","author":"Gauvreau","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pharmr.2026.100144_bib371","series-title":"Bancroft\u2019s Theory and Practice of Histological Techniques","first-page":"114","article-title":"9 - Theory of histological staining","author":"Horobin","year":"2019"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100144_bib372","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00418-022-02174-1","article-title":"Chloroacetate esterase reaction combined with immunohistochemical characterization of the specific tissue microenvironment of mast cells","volume":"159","author":"Atiakshin","year":"2023","journal-title":"Histochem Cell Biol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100144_bib373","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.jaci.2021.06.030","article-title":"Developing a standardized approach for assessing mast cells and eosinophils on tissue biopsies: a work group report of the AAAAI allergic skin diseases committee","volume":"148","author":"Zimmermann","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100144_bib374","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.3390\/cells8111429","article-title":"Mast cells in liver fibrogenesis","volume":"8","author":"Weiskirchen","year":"2019","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100144_bib375","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/s41591-019-0468-5","article-title":"A cellular census of human lungs identifies novel cell states in health and in asthma","volume":"25","author":"Vieira Braga","year":"2019","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100144_bib376","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1016\/j.jaci.2022.02.025","article-title":"Single-cell RNA sequencing of mast cells in eosinophilic esophagitis reveals heterogeneity, local proliferation, and activation that persists in remission","volume":"149","author":"Ben-Baruch Morgenstern","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"17","key":"10.1016\/j.pharmr.2026.100144_bib377","doi-asserted-by":"crossref","first-page":"5672","DOI":"10.7150\/jca.99554","article-title":"Single cell RNA-Sequencing Reveals Mast Cells Enhance Mononuclear phagocytes Infiltration in Bladder Cancer microenvironment","volume":"15","author":"Liu","year":"2024","journal-title":"J Cancer"},{"key":"10.1016\/j.pharmr.2026.100144_bib378","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.872688","article-title":"An optimized tissue dissociation protocol for single-cell RNA sequencing analysis of fresh and cultured human skin biopsies","volume":"10","author":"Burja","year":"2022","journal-title":"Front Cell Dev Biol"},{"issue":"18","key":"10.1016\/j.pharmr.2026.100144_bib379","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1182\/blood-2016-01-688887","article-title":"Neutrophil heterogeneity: implications for homeostasis and pathogenesis","volume":"127","author":"Silvestre-Roig","year":"2016","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100144_bib380","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1021\/acs.chemrev.7b00120","article-title":"Proteolytic cleavage-mechanisms, function, and \u201cOmic\u201d approaches for a near-ubiquitous posttranslational modification","volume":"118","author":"Klein","year":"2018","journal-title":"Chem Rev"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100144_bib381","doi-asserted-by":"crossref","first-page":"8315","DOI":"10.4049\/jimmunol.177.12.8315","article-title":"Human mast cell chymase cleaves pro-IL-18 and generates a novel and biologically active IL-18 fragment","volume":"177","author":"Omoto","year":"2006","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100144_bib382","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.immuni.2015.06.003","article-title":"Proteolytic processing of interleukin-1 family cytokines: variations on a common theme","volume":"42","author":"Afonina","year":"2015","journal-title":"Immunity"},{"issue":"17","key":"10.1016\/j.pharmr.2026.100144_bib383","doi-asserted-by":"crossref","first-page":"9017","DOI":"10.1073\/pnas.94.17.9017","article-title":"Chymase cleavage of stem cell factor yields a bioactive, soluble product","volume":"94","author":"Longley","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"issue":"36","key":"10.1016\/j.pharmr.2026.100144_bib384","doi-asserted-by":"crossref","first-page":"31707","DOI":"10.1074\/jbc.M111.233486","article-title":"Human tryptase cleaves pro-nerve growth factor (pro-NGF)","volume":"286","author":"Spinnler","year":"2011","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100144_bib385","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1172\/JCI119658","article-title":"Mast cell tryptase regulates rat colonic myocytes through proteinase-activated receptor 2","volume":"100","author":"Corvera","year":"1997","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100144_bib386","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1074\/jbc.272.7.4043","article-title":"Interactions of mast cell tryptase with thrombin receptors and PAR-2","volume":"272","author":"Molino","year":"1997","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100144_bib387","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-37598-3","article-title":"Tryptase \u03b2 regulation of joint lubrication and inflammation via proteoglycan-4 in osteoarthritis","volume":"14","author":"Das","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.pharmr.2026.100144_bib388","doi-asserted-by":"crossref","DOI":"10.1016\/j.jprot.2020.104089","article-title":"N-terminomics\u2014its past and recent advancements","volume":"233","author":"Kaushal","year":"2021","journal-title":"J Proteomics"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100144_bib389","doi-asserted-by":"crossref","DOI":"10.1002\/pro.4979","article-title":"Integrating the analysis of human biopsies using post-translational modifications proteomics","volume":"33","author":"Bhardwaj","year":"2024","journal-title":"Protein Sci"}],"container-title":["Pharmacological Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699726000323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699726000323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T10:26:45Z","timestamp":1785148005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031699726000323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":388,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0031699726000323"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmr.2026.100144","relation":{},"ISSN":["0031-6997"],"issn-type":[{"value":"0031-6997","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mast cell proteases and their significance in physiology, pathology, and therapeutic approaches","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmr.2026.100144","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"100144"}}